The Cannabis Company That Won't Mix Work With Pleasure
A limited supply of cannabis in the U.S. means those resources have to be divvied up carefully.
For Cronos Group, that means keeping its medical and recreational marijuana operations in completely different verticals, CEO Michael Gorenstein told Cheddar. That ensures patients’ needs are prioritized over those of recreational users.
“If you think about building a town, and you have a limited amount of building supplies, we want to make sure that we’re building a hospital before we’re building the bar,” he said.
Canada-based Cronos Group started trading on the NASDAQ on Tuesday, making it the first marijuana company to list on a major U.S. market.
“It’s a big milestone not just for us but for the entire industry,” said Gorenstein. “[It] just continues to show the acceptance that the cannabis industry is getting.”
And the industry does seem to be growing at break-neck speed. Arcview, a leading researcher of the cannabis market, stated in a [recent report](https://arcviewgroup.com/product/5th-edition/) that the industry brought in $9.7 billion in sales in 2017, and that number could grow to over $25 billion by 2021.
For the full interview, [click here](https://cheddar.com/videos/inside-the-first-cannabis-company-to-list-on-nasdaq).
David Bowie's entire catalog of songs has officially been sold to Warner Music Group by his estate for an estimated $250 million. This means the group now has the full rights to almost all of David Bowie's recordings. But Bowie, just the latest music mega deal. Just last month, Bruce Springsteen sold his entire catalog to Sony Music Entertainment at what in fact maybe be the biggest transaction ever for a single artist's body of work. In addition, John Legend also cashed in by selling rights to his songs from 2004 to early last year. Culture Correspondent at NPR, Anastasia Tsioulcas, joined Cheddar to discuss more.
Treasury officials say that filing taxes this year could be frustrating due to staffing shortages at the IRS and paperwork backlog. Cheddar News speaks with Brent Weiss, certified financial planner and co-founder of Facet Wealth, on how to best file your returns in 2022.
As the need for COVID-19 testing increases, so does the price of the tests themselves. An agreement with The White House and several major companies to sell the tests at a lower cost has now expired, sending prices up as retailers struggle to keep kits on shelves. Dr. Thomas McGinn, executive VP of physician enterprise at Common Spirit Health, joins Cheddar News to discuss.
With no end in sight to supply chain snarls, some companies are reconsidering the way they manufacture goods. Harry Moser, founder and president of Reshoring Initiative and Jennifer Smith, logistics and supply chain reporter for the Wall Street Journal, joined Cheddar News' Closing Bell to discuss some of the ways companies are trying to solve their supply chain problems in the long term.
Stocks closed higher Tuesday with the tech-heavy Nasdaq rising for a second straight day as tech stocks rebound. Investors also felt some relief after Federal Reserve Chair Jerome Powell today said the central bank is prepared to raise interest rates 'more over time' if inflation continues to run hot. Ross Mayfield, investment strategy analyst at Baird, joins Cheddar News' Closing Bell to discuss today's market close, whether and how markets are pricing in Fed activity, and more.
Bitcoin dipped below $40,000 this week amid a broader slump to begin the year. Some speculate that as cryptocurrencies correlate closer to traditional assets that factors like the Federal Reserve tightening monetary policy will weigh on digital coins. Jalak Jobanputra, managing partner at Future Perfect Ventures, joins Cheddar News' Closing Bell to discuss why crypto markets are feeling pressure from the Fed's potential 2022 rate hikes, broader crypto market predictions, and more.
